Larvol Delta - Conduit-Pharmaceuticals-Enters-into-Exclusive-License-Agreement-with-AstraZeneca-for-Multiple-Assets-to-Advance-Potential-FirstinClass-Treatments

AZD5658 - Conduit Pharmaceuticals

AZD1656 - Conduit Pharmaceuticals

https://www.globenewswire.com/news-release/2024/08/08/2926715/0/en/Conduit-Pharmaceuticals-Enters-into-Exclusive-License-Agreement-with-AstraZeneca-for-Multiple-Assets-to-Advance-Potential-First-in-Class-Treatments.html

Aug 8, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next